- Home
- DNTH vs TASK Comparison
DNTH vs TASK Comparison
Compare DNTH & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- TASK
- Stock Information
- Founded
- DNTH 2015
- TASK 2008
- Country
- DNTH United States
- TASK United States
- Employees
- DNTH N/A
- TASK N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- TASK Retail: Computer Software & Peripheral Equipment
- Sector
- DNTH Health Care
- TASK Technology
- Exchange
- DNTH Nasdaq
- TASK Nasdaq
- Market Cap
- DNTH 1.5B
- TASK 1.5B
- IPO Year
- DNTH N/A
- TASK 2021
- Fundamental
- Price
- DNTH $36.05
- TASK $13.35
- Analyst Decision
- DNTH Strong Buy
- TASK Buy
- Analyst Count
- DNTH 11
- TASK 4
- Target Price
- DNTH $65.22
- TASK $17.25
- AVG Volume (30 Days)
- DNTH 664.6K
- TASK 750.1K
- Earning Date
- DNTH 11-06-2025
- TASK 11-06-2025
- Dividend Yield
- DNTH N/A
- TASK N/A
- EPS Growth
- DNTH N/A
- TASK 21.25
- EPS
- DNTH N/A
- TASK 0.67
- Revenue
- DNTH $4,854,000.00
- TASK $1,101,465,000.00
- Revenue This Year
- DNTH N/A
- TASK $19.10
- Revenue Next Year
- DNTH N/A
- TASK $11.73
- P/E Ratio
- DNTH N/A
- TASK $19.91
- Revenue Growth
- DNTH 17.87
- TASK 19.04
- 52 Week Low
- DNTH $13.37
- TASK $11.26
- 52 Week High
- DNTH $40.16
- TASK $19.60
- Technical
- Relative Strength Index (RSI)
- DNTH 57.06
- TASK 19.21
- Support Level
- DNTH $33.34
- TASK $13.27
- Resistance Level
- DNTH $36.68
- TASK $14.04
- Average True Range (ATR)
- DNTH 2.11
- TASK 0.62
- MACD
- DNTH -0.53
- TASK -0.42
- Stochastic Oscillator
- DNTH 39.74
- TASK 5.26
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.